Boppli® Platform
Continuous blood pressure monitoring in neonatal and pediatric critical care
Key Facts
About PyrAmes
PyrAmes is a private, commercial-stage medical device company pioneering continuous non-invasive blood pressure (cNIBP) monitoring. Its core innovation is a wireless, calibration-free sensor technology that provides accurate, real-time blood pressure data, initially focused on the vulnerable neonatal and pediatric intensive care population with its FDA 510(k)-cleared Boppli® platform. The company is now developing its technology for adult inpatient (Bosimi®) and home diagnostic (Bosimi@Home™) markets, targeting a massive global need driven by hypertension and critical care monitoring gaps. Backed by recognition from the NIH, AHA, and FDA Breakthrough Device designation, PyrAmes is positioned to transform a foundational vital sign measurement.
View full company profile